Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)
NCT01412164
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
730
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
FIREHAWK biodegradable polymer rapamycin-eluting stent
Sponsor
Shanghai MicroPort Medical (Group) Co., Ltd.